HT9425-23-OCRP-OCCTA-LA: DoD Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Leadership Award
Closed
This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2023.
Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make $1.8 million in total. Applications closed on July 21, 2023.
From the official notice on Grants.gov, last changed March 22, 2023. Checked November 7, 2026.
- Total funding$1.8 million
- Cost sharingNot required
- Funding typeCooperative Agreement, Grant
Key dates
| Posted | March 22, 2023 |
|---|---|
| Deadline | July 21, 2023 |
| Archived by Grants.gov | August 20, 2023 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (59% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The OCRP established an Ovarian Cancer Academy (OCA) in 2009. The OCA is a unique, interactive virtual academy that provides intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA was to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment. In FY23, OCRP is initiating a new academy, the Ovarian Cancer Clinical Trial Academy (OCCTA), which will focus on clinical trial research in ovarian cancer. The intention of the OCCTA is to enhance knowledge within next generation of early career investigators in clinical trial research and to produce effective treatments and cures for ovarian cancer. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of Early Career Investigators (ECIs)/Scholars to conduct successful, highly productive clinical trials in ovarian cancer.
Who has won Military Medical Research and Development grants before
From fiscal 2021 to 2025, Military Medical Research and Development (12.420) awarded $6.9 billion across 5,470 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Maryland | 81 | $546 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 139 | $166 million |
| The Johns Hopkins University | Maryland | 157 | $153 million |
| The Regents of the University of California, San Francisco | California | 113 | $147 million |
| Duke University | North Carolina | 86 | $123 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HT9425-23-OCRP-OCCTA-LA still open?
No. It closed on July 21, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).
Who can apply for DoD Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Leadership Award?
Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.
What is the deadline for DoD Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Leadership Award?
Closed July 21, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $1.8 million in total.
Who has won Military Medical Research and Development grants before?
The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.